St. Johns Investment Management Company »

Mymd Pharmaceuticals shares owned by St. Johns Investment Management Company

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by St. Johns Investment Management Company from 13F filings

Historical chart of St. Johns Investment Management Company investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by St. Johns Investment Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by St. Johns Investment Management Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $28 18 1.61
2024-06-30 $32 18 1.83

More positions owned by St. Johns Investment Management Company

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Select Sector Spdr Tr Technology (XLK)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for St. Johns Investment Management Company

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
BlackRock
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Bryn Mawr Trust
Sandy Spring Bank
Advisor Group Holdings
Harbor Investment Advisory
Royal Bank of Canada
Tower Research Capital
Newbridge Financial Services Group

View all funds holding Mymd Pharmaceuticals